Kilitch Drugs (India) Limited (BOM:524500)

Kilitch Drugs (India) Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	167.76	98.01	189.62	198.46	100.62
Short-Term Investments	519.63	495.65	501.09	393.31	472.34
Cash & Short-Term Investments	687.39	593.66	690.71	591.77	572.96
Cash Growth	15.79%	-14.05%	16.72%	3.28%	17.17%
Accounts Receivable	1,202	847.39	632.24	542.87	414.12
Other Receivables	0.33	0.32	0.34	0.22	0.2
Receivables	1,202	847.71	632.58	543.09	414.32
Inventory	115.21	215.78	55.82	24.07	52.88
Prepaid Expenses	-	1.98	0.86	1.58	0.5
Other Current Assets	217.26	80.04	79.97	103.53	100.39
Total Current Assets	2,222	1,739	1,460	1,264	1,141
Property, Plant & Equipment	1,887	928.19	481.2	473.58	464.03
Long-Term Investments	228.87	228.6	228.47	226.78	260.68
Goodwill	176.93	185.36	193.79	202.21	210.64
Other Intangible Assets	2.64	3.52	4.44	2.63	2.34
Long-Term Deferred Tax Assets	45.82	28.79	25.63	19.78	15.12
Other Long-Term Assets	14.13	14.22	7.15	6.21	4.63
Total Assets	4,577	3,128	2,401	2,195	2,098

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	796.47	541.57	255.89	408.75	428.69
Accrued Expenses	52.36	17.43	15.97	16.44	14.48
Short-Term Debt	301.06	216.54	316.47	221.94	204.32
Current Income Taxes Payable	65.66	66.86	53.05	40.39	43.96
Other Current Liabilities	0.45	0.7	0.78	1.22	1.34
Total Current Liabilities	1,216	843.1	642.16	688.73	692.79
Long-Term Debt	586.04	277.7	-	-	-
Pension & Post-Retirement Benefits	6.79	2.45	1.72	0.68	2.75
Total Liabilities	1,809	1,123	643.88	689.41	695.55

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	349.62	160.82	160.82	155.82	155.82
Additional Paid-In Capital	-	466.84	466.84	383.26	383.26
Retained Earnings	-	1,267	1,000	854.29	749.81
Comprehensive Income & Other	2,447	128.32	134.95	122.6	101.97
Total Common Equity	2,797	2,023	1,763	1,516	1,391
Minority Interest	-27.86	-18.71	-6.18	-10.17	12.07
Shareholders' Equity	2,769	2,005	1,757	1,506	1,403
Total Liabilities & Equity	4,577	3,128	2,401	2,195	2,098

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	887.09	494.24	316.47	221.94	204.32
Net Cash (Debt)	-199.7	99.42	374.25	369.83	368.64
Net Cash Growth	-	-73.44%	1.19%	0.32%	8.11%
Net Cash Per Share	-5.90	3.09	11.75	11.87	11.84
Filing Date Shares Outstanding	34.24	32.16	32.16	31.16	31.16
Total Common Shares Outstanding	34.24	32.16	32.16	31.16	31.16
Working Capital	1,006	896.06	817.77	575.3	448.25
Book Value Per Share	81.67	62.90	54.81	48.64	44.63
Tangible Book Value	2,617	1,834	1,565	1,311	1,178
Tangible Book Value Per Share	76.43	57.03	48.65	42.07	37.80
Land	-	86.78	86.78	86.13	86.13
Buildings	-	41.72	40.02	40.02	39.43
Machinery	-	621.67	568.69	561.19	529.87
Construction In Progress	-	472.95	59.65	36.19	31.61

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 23, 2026

Data Sources Report a data error